Online tech company Hugel officially introduces Letybo in Malaysia
Hugel Inc. Expands Reach with Letybo Launch in Malaysia
Hugel Inc., a global leader in medical aesthetics, has made its mark in Southeast Asia with the launch of its premium toxin brand, Letybo, in Malaysia. The launch, which took place at the Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) in Malaysia, signifies a strategic move to tap into the growing market for aesthetic treatments in the region.
Letybo, introduced by Hugel Inc.'s Malaysian partner, Venusys Medical Sdn Bhd, was the centre of attention at the AMSC event. The conference, the largest medical aesthetics conference in Malaysia, was held from August 6 to 7, and attracted over 100 local medical professionals.
Konstantin Frank, a key opinion leader for Letybo in Europe, delivered a presentation at the AMSC event, focusing on the precise treatment outcomes and clinical strategies of botulinum toxin procedures. Frank also shared insights on integrating anatomical understanding with clinical expertise, and enhancing the results of such procedures.
Following the AMSC event, a hands-on workshop on botulinum toxin injection techniques took place on August 8 at The Zenith Hotel Kuantan. The workshop served as a training program for local medical professionals, aiming to equip them with the necessary skills to administer Letybo effectively.
Venusys Medical, headquartered in Malaysia and operating across Malaysia and Singapore, is the Malaysian partner for Hugel Inc. in the Letybo venture. The company, a distributor of medical aesthetic products and a long-standing partner of various global brands, is committed to helping Hugel Inc. solidify its position in the medical aesthetics market in Southeast Asia.
Hugel Inc., chaired by Suk Cha, is proactively positioning Letybo in Malaysia through educational events and strategic partnerships. The company aims to capitalize on the region's growing demand for aesthetic treatments and accelerate Letybo's market penetration in the region.
Southeast Asia, including Malaysia, presents a promising market for aesthetic treatments, making it a strategic location for Hugel Inc. to expand its reach and solidify its position as a premium toxin product provider. The company is planning to continue offering customized training programs for local medical professionals to ensure the highest standards of care are maintained.
With the successful launch of Letybo in Malaysia, Hugel Inc. is poised to make a significant impact in the Southeast Asian market, offering precision, expertise, and innovative solutions for medical aesthetics.
